Skip to main content

Bluejay Diagnostics, Inc.

corporate_fare Company Profile

Bluejay Diagnostics, Inc.

BJDX·NASDAQ·Industrial Applications And Services·CIK 0001704287

Bluejay Diagnostics, Inc. is a medical diagnostics company focused on improving patient outcomes in critical care settings, specifically sepsis. The company is developing rapid, near-patient tests using whole blood on its Symphony technology platform. The Symphony platform consists of an analyzer and single-use protein detection cartridges. Bluejay Diagnostics does not yet have regulatory clearance for Symphony and requires authorization from the U.S. Food and Drug Administration (FDA) before marketing it as a diagnostic product in the United States. The pre-clinical development of the Symphony analyzer has been completed. In 2026, the company transferred the knowledge, technology, and process for producing Symphony cartridges from the original developer and outside supplier, Toray Industries, to a contract manufacturing facility with FDA certification run by Sanyoseiko. Bluejay Diagnostics is collaborating with Sanyoseiko to modify the manufacturing process of the Symphony cartridges to address technical issues and meet performance and quality requirements for regulatory submission. The Symphony platform combines Bluejay's intellectual property and exclusively licensed and patented intellectual property on the Symphony technology. The Symphony device candidate is designed to produce laboratory-quality results in approximately 20 minutes in critical care settings, including Intensive Care Units (ICUs) and Emergency Rooms (ERs). The company's first product candidate, the Symphony IL-6 test, is an immunoassay for measuring interleukin-6 (IL-6) to monitor disease progression in critical care settings, with a current focus on sepsis.

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 40 items for BJDX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for BJDX spans 10-Q, 8-K, 424B3, S-3.

Recent high-impact activity:

  • Bluejay Q3: $7.4M Cash, Going Concern Reaffirmed, $10-14M Raise Still Needed
  • Bluejay Sets 1-for-4 Reverse Split Effective November 3 to Shore Up Nasdaq Listing
  • Bluejay Diagnostics Completes SYMON-II Enrollment, Reports $9.6M Cash
  • Bluejay Completes SYMON-II Enrollment, Cash Runway Extended to Q2 2027
  • Bluejay Diagnostics Extends Cash Runway to Q2 2027, Reports $4.2M Net Loss

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$6.85M
Diluted EPS
-$15.25
Op. Cash Flow
-$6.05M
Free Cash Flow
-$6.23M
Operating Income
-$6.95M
Cash & Equivalents
$5.16M
Debt / Equity
0.00×
Shares Outstanding
604.53K sh
Source: 10-K · filed 2026-03-06 · accession 0001213900-26-024616

Short Interest & Short Volume

1.01 days to cover

FINRA reported short interest of 77,889 shares in BJDX as of the October 30, 2026 settlement, a 46.1% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 13, 2026, 61.1% of BJDX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)77,889 shares as of October 30, 2026
Change vs prior period▼ 46.1%
Days to cover1.01 at avg daily volume of 77,098
Daily short volume (FINRA facilities)61.1% of 14,250 shares on November 13, 2026
5-day average short volume56.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for BJDX, detected from its recent SEC filings · based on capital-structure filings through 2026-06-26.

1 shelf registrationreverse split

Massive Share Registration for Resale · Extreme Potential Dilution

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with B →
$2.61
52-week range · as of 2026-11-12 $1.84 – $28
Market cap
$2.92M
Volume
37K (0.3× avg)
3-mo avg 106.9K
Live data · 2026-11-16 02:54 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BJDX - Latest Insights

BJDX
Nov 12, 2026, 5:00 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.61
Real-time Price: $2.61 info
Change: +$0.0050 (+0.19%) info
Market Cap: $2.915M info
BJDX
Oct 30, 2026, 10:30 AM EDT
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $0.4615
Real-time Price: $2.61 info
Change: Reverse Stock Split info
Market Cap: $2.915M info
BJDX
Aug 13, 2026, 7:56 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.03
Real-time Price: $2.61 info
Change: Reverse Stock Split info
Market Cap: $2.915M info
BJDX
Aug 13, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.05
Real-time Price: $2.61 info
Change: Reverse Stock Split info
Market Cap: $2.915M info
BJDX
Aug 12, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.05
Real-time Price: $2.61 info
Change: Reverse Stock Split info
Market Cap: $2.915M info
BJDX
Jul 22, 2026, 5:25 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.14
Real-time Price: $2.61 info
Change: Reverse Stock Split info
Market Cap: $2.915M info
BJDX
Jul 21, 2026, 6:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.17
Real-time Price: $2.61 info
Change: Reverse Stock Split info
Market Cap: $2.915M info
BJDX
Jun 26, 2026, 4:44 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $2.98
Real-time Price: $2.61 info
Change: Reverse Stock Split info
Market Cap: $2.915M info
BJDX
Jun 17, 2026, 5:20 PM EDT
Filing Type: S-3
Importance Score:
9
Price at Filing: $4.44
Real-time Price: $2.61 info
Change: Reverse Stock Split info
Market Cap: $2.915M info
BJDX
Jun 09, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.82
Real-time Price: $2.61 info
Change: Reverse Stock Split info
Market Cap: $2.915M info
BJDX
Jun 08, 2026, 5:23 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $5.00
Real-time Price: $2.61 info
Change: Reverse Stock Split info
Market Cap: $2.915M info
BJDX
Jun 08, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $5.01
Real-time Price: $2.61 info
Change: Reverse Stock Split info
Market Cap: $2.915M info
BJDX
Jun 05, 2026, 8:13 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $4.65
Real-time Price: $2.61 info
Change: Reverse Stock Split info
Market Cap: $2.915M info
BJDX
Jun 02, 2026, 9:00 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $4.09
Real-time Price: $2.61 info
Change: Reverse Stock Split info
Market Cap: $2.915M info
BJDX
Jun 02, 2026, 8:10 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $4.09
Real-time Price: $2.61 info
Change: Reverse Stock Split info
Market Cap: $2.915M info
BJDX
Jun 02, 2026, 12:19 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $4.63
Real-time Price: $2.61 info
Change: Reverse Stock Split info
Market Cap: $2.915M info
BJDX
Jun 02, 2026, 6:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.18
Real-time Price: $2.61 info
Change: Reverse Stock Split info
Market Cap: $2.915M info
BJDX
Jun 02, 2026, 6:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.76
Real-time Price: $2.61 info
Change: Reverse Stock Split info
Market Cap: $2.915M info
BJDX
May 18, 2026, 5:21 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $1.79
Real-time Price: $2.61 info
Change: Reverse Stock Split info
Market Cap: $2.915M info
BJDX
May 18, 2026, 5:20 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $1.79
Real-time Price: $2.61 info
Change: Reverse Stock Split info
Market Cap: $2.915M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets